XBIT
XBIT
NASDAQ · Biotechnology

Xbiotech Inc

$2.15
+0.00 (+0.00%)
As of Sep 29, 3:16 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +456.7% upside
Low Target $8.96
Average Target $11.97
High Target $15.34
Current Price $2.15
Current
$2.15
Target
$11.97
$8.96 $11.97 avg $15.34
Scenario Analysis
Bear Case
$8.96
316.7%
Low target
Base Case
$11.97
+456.7%
Avg target
Bull Case
$15.34
+613.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.44
-37.5% from high
52-Week Low
$2.09
+2.9% from low
Target vs 52W High
$11.97
+248.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%